Princeton-based Integra LifeSciences Corporation Holdings announced several leadership appointments within its commercial organization.
Robert Davis Jr. is a newly named executive vice president, Tissue Reconstruction and Distributed Technologies, and will lead the wound reconstruction and soft tissue segments, as well as private label.
Christopher Kilburn-Peterson was promoted to corporate vice president and president for the Tissue Reconstruction division, reporting to Davis.
This follows the recent appointment of Mike McBreen as executive vice president and chief commercial officer.
Harvinder Singh, who previously led the international business, succeeds McBreen as executive vice president and president of the Specialty Surgery division, leading its commercial and portfolio strategy and business performance.
These changes are designed to strengthen customer focus, accelerate execution, and support the company’s long-term growth strategy, according to a company release.
In February, Integra named Teshtar Elavia a corporate vice president and chief technology officer.
